Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy

Journal of Gastroenterology

Volumn 46, Issue 6, 2011, Pages 758-768

  Tanaka, Naoki ^a,b   Horiuchi, Akira ^c   Yokoyama, Takahide ^b   Kaneko, Gengo ^d   Horigome, Naoto ^d   Yamaura, Takahiro ^d   Nagaya, Tadanobu ^b   Komatsu, Michiharu ^b   Sano, Kenji ^e   Miyagawa, Shin Ichi ^b   Aoyama, Toshifumi ^a   Tanaka, Eiji ^b  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Showa Inan General Hospital   (Japan)

^d Iida Municipal Hospital   (Japan)

^e SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Albumin; Apolipoprotein B; Nonalcoholic steatohepatitis; Pancreatic exocrine insufficiency; Pancreatic head cancer

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; APOLIPOPROTEIN B; ASPARTATE AMINOTRANSFERASE; BERIZYM; CHOLESTEROL; CHOLINESTERASE; GAMMA GLUTAMYLTRANSFERASE; PANCREAS ENZYME; PANCREATIN; TOUGHMAC E; UNCLASSIFIED DRUG; ZINC;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIVER BIOPSY; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PANCREAS CANCER; PANCREATICODUODENECTOMY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; WEIGHT REDUCTION; ZINC BLOOD LEVEL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYMES; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PANCREATICODUODENECTOMY; PREVALENCE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79960215132     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-011-0370-5     Document Type: Article

References (29)

1. de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol. 2008;48:S104-12.
2. Ono M, Saibara T. Clinical features of nonalcoholic steatohepatitis in Japan: evidence from the literature. J Gastroenterol. 2006;41:725-32. (Pubitemid 44446124)
3. Shimada M, Hashimoto E, Taniai M, Hasegawa K, Okuda H, Hayashi N, et al. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Hepatol. 2002;37:154-60. (Pubitemid 34713069)
4. Nagaya T, Tanaka N, Komatsu M, Ichijo T, Sano K, Horiuchi A, et al. Development from simple steatosis to liver cirrhosis and hepatocellular carcinoma: a 27-year follow-up case. Clin J Gastroenterol. 2008;1:116-21.
5. Dresler CM, Fortner JG, McDermott K, Bajorunas DR. Metabolic consequences of (regional) total pancreatectomy. Ann Surg. 1991;214:131-40.
6. Nomura R, Ishizaki Y, Suzuki K, Kawasaki S. Development of hepatic steatosis after pancreatoduodenectomy. AJR Am J Roentgenol. 2007;189:1484-8. (Pubitemid 350174817)
7. Miyagawa S, Makuuchi M, Kawasaki S, Ogiwara M. Secondstage pancreatojejunostomy following pancreatoduodenectomy in high-risk patients. Am J Surg. 1994;168:66-8. (Pubitemid 24331020)
8. Ricci C, Longo R, Gioulis E, Bosco M, Pollesello P, Masutti F, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 1997;27:108-13. (Pubitemid 27357063)
9. Komatsu M, Yazaki M, Tanaka N, Sano K, Hashimoto E, Takei Y, et al. Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease. J Hepatol. 2008;49: 810-20.
10. Tanaka N, Tanaka E, Sheena Y, Komatsu M, Okiyama W, Misawa N, et al. Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population. Liver Int. 2006;26:956-63. (Pubitemid 44323414)
11. Tanaka N, Nagaya T, Komatsu M, Horiuchi A, Tsuruta G, Shirakawa H, et al. Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum amino-transferase. Liver Int. 2008;28:1104-11.
12. Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol. 2008;42: 413-8. (Pubitemid 351450629)
13. Nagaya T, Tanaka N, Suzuki T, Sano K, Horiuchi A, Komatsu M, et al. Down-regulation of SREBP-1c is associated with the development of burned-out NASH. J Hepatol. 2010;53:724-31.
14. Tsutsui M, Tanaka N, Kawakubo M, Sheena Y, Horiuchi A, Komatsu M, et al. Serum fragmented cytokeratin 18 levels reflect the histological activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels. J Clin Gastroenterol. 2010;44:440-7.
15. Tsuruta G, Tanaka N, Hongo M, Komatsu M, Horiuchi A, Hamamoto K, et al. Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits. J Gastroenterol. 2010;45:666-72.
16. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, et al. Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb. 2006;13: 202-8.
17. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-21. (Pubitemid 40770284)
18. Neuschwander-Tetri BA, Clark JM, Bass NM, Van Natta ML, Unalp-Arida A, Tonascia J, et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology. 2010;52:913-24.
19. Kato H, Isaji S, Azumi Y, Kishiwada M, Hamada T, Mizuno S, et al. Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system. J Hepatobiliary Pancreat Surg. 2010;17:296-304.
20. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745-50. (Pubitemid 34977081)
21. Hatta T, Fujinaga Y, Kadoya M, Ueda H, Murayama H, Kurozumi M, et al. Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease. J Gastroenterol. 2010;45:1263-71.
22. Nakanuma Y, Ohta G, Konishi I, Shima Y. Liver injury with perivenular fibrosis and alcoholic hyalin after pancreatoduodenectomy for pancreatic carcinoma. Acta Pathol Jpn. 1987;37: 1953-60. (Pubitemid 18012168)
23. Tanaka N, Horiuchi A, Yokoyama T, Kawa S, Kiyosawa K. Pancreatic exocrine insufficiency: a rare cause of nonalcoholic steatohepatitis. Am J Gastroenterol. 2008;103:245-6.
24. Rinella ME, Green RM. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J Hepatol. 2004;40:47-51. (Pubitemid 38064712)
25. Rinella ME, Elias MS, Smolak RR, Fu T, Borensztajn J, Green RM. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J Lipid Res. 2008;49:1068-76.
26. Tanaka N, Moriya K, Kiyosawa K, Koike K, Gonzalez FJ, Aoyama T. PPARa activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J Clin Invest. 2008;118:683-94. (Pubitemid 351206557)
27. Okiyama W, Tanaka N, Nakajima T, Tanaka E, Kiyosawa K, Gonzalez FJ, et al. Polyenephosphatidylcholine prevents alcoholic liver disease in PPARa-null mice through attenuation of increases in oxidative stress. J Hepatol. 2009;50:1236-46.
28. Kang X, Zhong W, Liu J, Song Z, McClain CJ, Kang YJ, et al. Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha. Hepatology. 2009;50:1241-50.
29. Purohit V, Bode JC, Bode C, Brenner DA, Choudhry MA, Hamilton F, et al. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol. 2008;42:349-61.